Eugeniu Strelet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Eugeniu Strelet has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Marco Seabra Reis
University of Coimbra, CERES, Department of Chemical Engineering, 3030-790 Coimbra, Portugal
4 shared publications Ricardo Rendall
The Dow Chemical Company, Lake Jackson, Texas 77566, United States
2 shared publications- You Peng
Chemometrics, AI and Statistics, Technical Expertise and Support
2 shared publications - Ana Alarcão
Institute of Anatomical and Molecular Pathology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
1 shared publication - Ana F. Ladeirinha
Institute of Anatomical and Molecular Pathology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
1 shared publication - Birgit Braun
The Dow Chemical Company, Midland, MI 48674, USA
1 shared publication
Latest Publications
- 19 November 2024
- Published by American Chemical Society (ACS) in Industrial & Engineering Chemistry Research
- Vol. 63 (48) , 20989-21000
Regularized Bayesian Fusion for Multimodal Data Integration in Industrial Processes
- 19 November 2024
- Published by American Chemical Society (ACS) in Industrial & Engineering Chemistry Research
- Vol. 63 (48) , 20989-21000
Regularized Bayesian Fusion for Multimodal Data Integration in Industrial Processes
- Open Access
- 20 November 2023
- Published by Elsevier in Journal of Environmental Chemical Engineering
- Vol. 11 (6)
Multi-source and multimodal data fusion for improved management of a wastewater treatment plant
- 20 November 2023
- Published by Elsevier in Journal of Environmental Chemical Engineering
- Vol. 11 (6)
Open AccessMulti-source and multimodal data fusion for improved management of a wastewater treatment plant
- 26 October 2023
- Published by Springer Nature in Medical Oncology
- Vol. 40 (12) , 1-8
Hepatocellular carcinoma: tumor heterogeneity and recurrence after preoperative locoregional therapy
How locoregional therapy (LRT) may change tumor compositional and functional heterogeneity, consequently contributing to treatment resistance and tumor recurrence remains largely unknown. A series of hepatocellular carcinomas (HCCs) treated with preoperative locoregional therapy (LRT) that relapsed after surgery was studied. Thirty HCCs comprising 15 patients treated with LRT prior to liver transplantation (n = 14)/surgical resection (n = 1) were studied. Five patients undergoing pre-transplant LRT, comprising 11 HCCs, presented tumor recurrence (median recurrence time = 10 months). Clinicopathological data and immunoexpression of proliferation markers (Ki67, p53), cholangiocytic/hepatic progenitor cell (HPC) markers (EpCAM)/BerEp4, CK19, CK7) and mesenchymal markers (ASMA, vimentin) were evaluated in tumoral epithelial/stromal cells and in peritumoral parenchyma. Higher grading of tumor differentiation, microvascular invasion and tumoral cell p53 expression significantly associated with recurrence (p < 0.05). Piecemeal necrosis features were more frequent in tumors that recurred (p < 0,05). Tumoral and peritumoral Ki67 expression and EpCAM, CK19 and CK7 expression in tumoral cells tended to be higher in treated tumors that recurred. Peritumoral expression of cholangiocytic/HPC markers and tumoral epithelial and stromal cellular expression of mesenchymal markers tended to be higher for tumors without recurrence. Recurrence after transplant with preoperative LRT might be associated with poor HCC differentiation, higher cellular proliferation rate, peritumoral piecemeal necrosis features and cholangiocytic/HPC phenotypes. Understanding HCC progression factors after LRT might be important for optimizing patient selection for treatment, improving surveillance after LRT and to explore synergies between LRT and systemic targeted therapies to prevent recurrence.
- 26 October 2023
- Published by Springer Nature in Medical Oncology
- Vol. 40 (12) , 1-8
Hepatocellular carcinoma: tumor heterogeneity and recurrence after preoperative locoregional therapy
How locoregional therapy (LRT) may change tumor compositional and functional heterogeneity, consequently contributing to treatment resistance and tumor recurrence remains largely unknown. A series of hepatocellular carcinomas (HCCs) treated with preoperative locoregional therapy (LRT) that relapsed after surgery was studied. Thirty HCCs comprising 15 patients treated with LRT prior to liver transplantation (n = 14)/surgical resection (n = 1) were studied. Five patients undergoing pre-transplant LRT, comprising 11 HCCs, presented tumor recurrence (median recurrence time = 10 months). Clinicopathological data and immunoexpression of proliferation markers (Ki67, p53), cholangiocytic/hepatic progenitor cell (HPC) markers (EpCAM)/BerEp4, CK19, CK7) and mesenchymal markers (ASMA, vimentin) were evaluated in tumoral epithelial/stromal cells and in peritumoral parenchyma. Higher grading of tumor differentiation, microvascular invasion and tumoral cell p53 expression significantly associated with recurrence (p < 0.05). Piecemeal necrosis features were more frequent in tumors that recurred (p < 0,05). Tumoral and peritumoral Ki67 expression and EpCAM, CK19 and CK7 expression in tumoral cells tended to be higher in treated tumors that recurred. Peritumoral expression of cholangiocytic/HPC markers and tumoral epithelial and stromal cellular expression of mesenchymal markers tended to be higher for tumors without recurrence. Recurrence after transplant with preoperative LRT might be associated with poor HCC differentiation, higher cellular proliferation rate, peritumoral piecemeal necrosis features and cholangiocytic/HPC phenotypes. Understanding HCC progression factors after LRT might be important for optimizing patient selection for treatment, improving surveillance after LRT and to explore synergies between LRT and systemic targeted therapies to prevent recurrence.
- 12 July 2023
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1276, 341601
A new process analytical technology soft sensor based on electrical tomography for real-time monitoring of multiphase systems
- 12 July 2023
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1276, 341601
A new process analytical technology soft sensor based on electrical tomography for real-time monitoring of multiphase systems
- 22 November 2022
- Published by American Chemical Society (ACS) in Industrial & Engineering Chemistry Research
- Vol. 61 (48) , 17544-17556
A Federated Classification Approach of Waste Lubricant Oils in Geographically Distributed Laboratories
- 22 November 2022
- Published by American Chemical Society (ACS) in Industrial & Engineering Chemistry Research
- Vol. 61 (48) , 17544-17556
A Federated Classification Approach of Waste Lubricant Oils in Geographically Distributed Laboratories